Introduction to BPC-157
BPC-157 (Body Protective Compound-157) is a synthetic peptide consisting of 15 amino acids. It is derived from a partial sequence of the human gastric juice protein known as Body Protective Compound (BPC). Unlike many peptides studied in isolation, BPC-157 has demonstrated a remarkable range of biological activities across multiple tissue types.
Research Background
The majority of BPC-157 research has been conducted in animal models (primarily rats), where researchers have observed consistent and reproducible effects on tissue repair, inflammation modulation, and organ protection. The peptide has been studied since the 1990s, with the bulk of foundational research coming from the University of Zagreb in Croatia.
Mechanisms of Action
BPC-157 appears to work through several overlapping pathways:
- Nitric Oxide (NO) system modulation — BPC-157 interacts with the NO synthesis pathway, which plays a critical role in vasodilation and blood flow to injured tissues.
- Growth hormone receptor upregulation — Research suggests BPC-157 may enhance sensitivity to growth hormone, amplifying downstream repair processes.
- Angiogenesis promotion — The peptide appears to promote the formation of new blood vessels, critical for delivering nutrients to healing tissue.
- Tendon fibroblast activation — Multiple studies have noted significant proliferation of tendon fibroblasts in the presence of BPC-157.
Key Research Findings
Animal studies have investigated BPC-157 across a wide range of injury models, including tendon transection, muscle crush injuries, bone fractures, and gastrointestinal damage. Consistent themes across the literature include accelerated healing timelines and reduced inflammatory markers.
Important Disclaimer
All information on this site is for educational and research purposes only. BPC-157 is a research peptide and has not been approved by the FDA for human use. Consult a qualified healthcare professional before considering any peptide protocol.